Biodexa Pharmaceuticals
4.16
-0.08 (-1.89%)
At close: Jan 15, 2025, 11:24 AM

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12
Cash & Equivalents 5.97M 2.84M 10.06M 7.55M 10.93M 2.34M 13.20M 17.61M 16.18M 30.32M 2.39M 133.00K
Short-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 12.00K 49.00K
Other Long-Term Assets n/a -837.00K -1.15M -542.00K 2.63M 469.00K 465.00K 448.00K 387.00K 425.00K 379.00K -927.00K
Receivables 704.00K 329.00K 33.00K 95.00K 22.00K 89.00K 2.23M 1.43M 985.00K 189.00K 160.00K n/a
Inventory -704.00K 1.00 1.00 -1.38M 1.00 n/a 941.00K 817.00K 459.00K n/a n/a n/a
Other Current Assets 1.06M 376.00K 607.00K 258.00K 2.79M 3.19M 2.21M 2.45M 2.71M 1.11M 1.55M 964.00K
Total Current Assets 7.03M 4.69M 11.76M 9.28M 13.74M 5.62M 18.58M 22.30M 20.33M 31.63M 4.09M 1.10M
Property-Plant & Equipment 571.00K 831.00K 1.15M 542.00K 2.15M 1.98M 2.53M 2.77M 1.98M 1.52M 684.00K 876.00K
Goodwill & Intangibles 2.94M 6.00K n/a n/a 12.38M 12.37M 27.65M 31.17M 41.34M 13.09M 4.00K 2.00K
Total Long-Term Assets 3.51M 837.00K 1.15M 542.00K 17.16M 14.83M 30.64M 34.39M 43.71M 15.04M 1.08M 927.00K
Total Assets 10.54M 5.53M 12.91M 9.82M 30.89M 20.44M 49.22M 56.69M 64.04M 46.66M 5.17M 2.22M
Account Payables 314.00K 339.00K 485.00K 337.00K 725.00K 286.00K 2.27M 3.27M 2.29M 981.00K 522.00K 563.00K
Deferred Revenue n/a 197.00K n/a 68.00K n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt 169.00K 161.00K 146.00K 200.00K 412.00K 368.00K 361.00K 538.00K 442.00K 491.00K 1.25M n/a
Other Current Liabilities 5.02M 1.32M 1.15M 2.42M 4.44M 1.82M 5.73M 5.54M 6.37M 1.36M 568.00K 4.50M
Total Current Liabilities 5.57M 1.90M 1.84M 2.99M 5.67M 2.47M 8.36M 9.35M 9.10M 2.83M 2.29M 5.07M
Long-Term Debt 295.00K 463.00K 620.00K 60.00K 5.67M 884.00K 6.18M 1.62M 1.51M 1.49M 2.12M 2.17M
Other Long-Term Liabilities n/a n/a -469 50.00K n/a 165.00K n/a n/a 6.55M 354.00K n/a -2.17M
Total Long-Term Liabilities 295.00K 463.00K 619.53K 110.00K 5.67M 1.05M 6.18M 1.62M 8.05M 1.84M 2.12M 2.17M
Total Liabilities 5.86M 2.36M 2.46M 3.10M 11.34M 3.52M 14.55M 10.96M 17.15M 4.67M 4.41M 7.31M
Total Debt 464.00K 624.00K 766.00K 260.00K 6.08M 1.17M 6.51M 2.13M 1.88M 1.94M 3.32M n/a
Common Stock 1.19M 1.11M 98.47K 63.00K 23.00K 3.00K 3.00K 2.00K 2.00K 1K n/a n/a
Retained Earnings -144.77M -135.34M -127.80M -122.43M -99.84M -89.72M -74.65M -59.11M -39.15M -29.22M -20.40M -17.19M
Comprehensive Income 61.52M 53.00M 53.00M 53.00M 53.49M 53.70M 56.39M 57.62M 54.39M 39.57M 142.00K n/a
Shareholders Equity 4.68M 3.16M 10.45M 6.72M 19.56M 16.92M 34.68M 45.72M 46.89M 41.99M 760.00K -5.09M
Total Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 12.00K 49.00K